Cognitive Muscular Therapy for Long-COVID and Breathing Issues
Cognitive Muscular Therapy for Patients With Long-COVID (Post COVID-19) and Breathing Pattern Disorder
This study is testing a new breathing therapy for people with long-COVID to see if it can help them breathe better and feel more energetic.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Salford Academic / other |
| Locations | 1 site (Manchester, Greater Manchester) |
| Trial ID | NCT06503913 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of Cognitive Muscular Therapy (CMT) in alleviating breathlessness and improving autonomic function in patients suffering from long-COVID. The intervention incorporates a novel system that visualizes breathing mechanics in real-time, allowing patients to better understand and control their breathing patterns. By combining psychological insights with physiotherapy, CMT seeks to address dysfunctional breathing and its associated symptoms, such as dizziness and fatigue. The study will involve 20 participants who will undergo this integrated therapy to assess improvements in respiratory function and overall well-being.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 experiencing moderate to severe breathlessness due to long-COVID.
Not a fit: Patients with significant respiratory co-morbidities or major cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly reduce breathlessness and improve quality of life for long-COVID patients.
How similar studies have performed: While similar approaches have been explored, this specific integration of breathing visualization with cognitive therapy is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Above 18 years old * Experience moderate/severe breathlessness, quantified using the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) scale. * Speak and understand English sufficiently to read the information sheet and sign the consent form * Ability to stand without any assistive device for at least 20 minutes (to ensure sufficient capacity to complete the intervention) Exclusion Criteria: * Dementia or other major cognitive impairment * BMI \>32 (as increased subcutaneous fat prevents use of breathing measurement system) * Current smoker or smoked regularly within last 6 months * Any cardiorespiratory disease that requires medical intervention (except asthma management) * Currently receiving physiotherapy-based treatment for LC or breathing pattern disorder * Significant respiratory co-morbidity (e.g. COPD, uncontrolled Asthma)
Where this trial is running
Manchester, Greater Manchester
- University of Salford — Manchester, Greater Manchester, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Stephen J Preece, PhD
- Email: s.preece@salford.ac.uk
- Phone: +441612952273
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.